Preview Mode Links will not work in preview mode

This Week in Cardiology

Apr 9, 2021

COVID-19, COVID-19 vaccines, hybrid AF ablation TAVR and who gets to be called a doctor are the topics by John Mandrola, MD, in this week’s podcast.


UK Regulators to Offer Under-30s Alternative to AZ COVID Vaccine

- News - Communicating the potential benefits and harms of the Astra-Zeneca COVID-19 vaccine

Hybrid Ablation for Persistent AF

- Hybrid Convergent Procedure for the Treatment of Persistent and Long-Standing Persistent Atrial Fibrillation

- Converge trial Rationale Paper

- Approaches to Catheter Ablation for Persistent Atrial Fibrillation

- Toward evidence-based medical statistics. 2: The Bayes factor


- TAVR Feasible, Comparable to Surgery in Rheumatic Heart Disease

- Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Rheumatic Aortic Stenosis

- Upsides, Downsides for TAVR, Minimally Invasive AVR

- Minimally invasive surgery versus transcatheter aortic valve replacement: a systematic review and meta-analysis

Who Should Get to Be Called 'Doctor'?

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact